Your browser doesn't support javascript.
loading
Modeling apoptosis resistance in CHO cells with CRISPR-mediated knockouts of Bak1, Bax, and Bok.
MacDonald, Michael A; Barry, Craig; Groves, Teddy; Martínez, Verónica S; Gray, Peter P; Baker, Kym; Shave, Evan; Mahler, Stephen; Munro, Trent; Marcellin, Esteban; Nielsen, Lars K.
Afiliación
  • MacDonald MA; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Barry C; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Groves T; The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.
  • Martínez VS; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Gray PP; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Baker K; Patheon by Thermo Fisher Scientific, Woolloongabba, Queensland, Australia.
  • Shave E; Patheon by Thermo Fisher Scientific, Woolloongabba, Queensland, Australia.
  • Mahler S; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Munro T; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Marcellin E; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia.
  • Nielsen LK; Metabolomics Australia, The University of Queensland, Brisbane, Queensland, Australia.
Biotechnol Bioeng ; 119(6): 1380-1391, 2022 06.
Article en En | MEDLINE | ID: mdl-35180317
ABSTRACT
Chinese hamster ovary (CHO) cells are the primary platform for the production of biopharmaceuticals. To increase yields, many CHO cell lines have been genetically engineered to resist cell death. However, the kinetics that governs cell fate in bioreactors are confounded by many variables associated with batch processes. Here, we used CRISPR-Cas9 to create combinatorial knockouts of the three known BCL-2 family effector proteins Bak1, Bax, and Bok. To assess the response to apoptotic stimuli, cell lines were cultured in the presence of four cytotoxic compounds with different mechanisms of action. A population-based model was developed to describe the behavior of the resulting viable cell dynamics as a function of genotype and treatment. Our results validated the synergistic antiapoptotic nature of Bak1 and Bax, while the deletion of Bok had no significant impact. Importantly, the uniform application of apoptotic stresses permitted direct observation and quantification of a delay in the onset of cell death through Bayesian inference of meaningful model parameters. In addition to the classical death rate, a delay function was found to be essential in the accurate modeling of the cell death response. These findings represent an important bridge between cell line engineering strategies and biological modeling in a bioprocess context.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Apoptosis / Proteínas Proto-Oncogénicas c-bcl-2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Biotechnol Bioeng Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Apoptosis / Proteínas Proto-Oncogénicas c-bcl-2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Biotechnol Bioeng Año: 2022 Tipo del documento: Article País de afiliación: Australia